阅读说明：本技术 马赛替尼的晶型 (Crystalline forms of masitinib ) 是由 N·马丁 D·费舍尔-达乌特 于 2018-03-22 设计创作，主要内容包括：本发明涉及甲磺酸马赛替尼的多晶型物、其制备方法、包含其的药物组合物及其医学用途。(The present invention relates to polymorphs of masitinib mesylate, processes for their preparation, pharmaceutical compositions comprising them and their medical use.)